{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:46:17Z","timestamp":1793936777449,"version":"4.8.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>We prospectively analyzed antifungal use in immunocompromised children through a multicenter 12-week weekly point-prevalence survey in 31 hematology-oncology (HO) and hematopoietic stem cell\/solid organ transplant (HSCT\/SOT) units of 18 hospitals in 11 European countries. All patients hospitalized and receiving systemic antifungals were included. Ward policies, and weekly ward\/patient data were collected. All 21 HO and 10 HSCT\/SOT units had prophylaxis policies for high-risk patients (27\/31 used azoles, 14\/31 echinocandins and 15\/31 liposomal amphotericin B [LAMB]). Among 572 courses recorded, prophylaxis was indicated in 439\/572 (77%) and treatment in 133\/572 (62\/133 empirical, 43\/133 pre-emptive, 28\/133 targeted). Among patients receiving prophylaxis, 56% belonged to the non-high-risk group. Most common reasons for empirical, pre-emptive and targeted treatment were antibiotic-resistant febrile neutropenia (52%), abnormalities on chest-CT with\/without positive galactomannan (77%) and candidiasis (82%), respectively. Fluconazole and LAMB were the most frequently prescribed agents both for prophylaxis (31%, 21%) and treatment (32%, 23%). Underdosing of micafungin for treatment in 50% of prescriptions and of fluconazole for treatment and prophylaxis in 70% of cases was noticed. In conclusion, most antifungal prescribing was for prophylaxis, with fluconazole being the main antifungal prescribed. Inadequate doses of antifungal prescribing and prophylaxis of non-high-risk patients could be targets for improvement.<\/jats:p>","DOI":"10.1097\/mph.0000000000003070","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:00:22Z","timestamp":1750690822000},"page":"e222-e230","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)"],"prefix":"10.1097","volume":"47","author":[{"given":"Elisavet","family":"Chorafa","sequence":"first","affiliation":[{"name":"Third Department of Pediatrics, Infectious Diseases Unit, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9881-451X","authenticated-orcid":false,"given":"Elias","family":"Iosifidis","sequence":"additional","affiliation":[{"name":"Third Department of Pediatrics, Infectious Diseases Unit, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Oletto","sequence":"additional","affiliation":[{"name":"Fondazione Penta ETS, Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adilia","family":"Warris","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Health and Life Sciences, University of Exeter, Medical Research Council Center for Medical Mycology, Exeter, United Kingdom"},{"name":"European Pediatric Mycology Network"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5336-8429","authenticated-orcid":false,"given":"Elio","family":"Castagnola","sequence":"additional","affiliation":[{"name":"European Pediatric Mycology Network"},{"name":"Pediatric Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Bruggemann","sequence":"additional","affiliation":[{"name":"European Pediatric Mycology Network"},{"name":"Department of Pharmacy, Centre of Expertise in Mycology Radboudumc\/Canisius-Wilhelmina Hospital, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[{"name":"European Pediatric Mycology Network"},{"name":"Department of Pediatric Hematology\/Oncology, University Children\u2019s Hospital, Infectious Disease Research Program, Center for Bone Marrow Transplantation, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[{"name":"European Pediatric Mycology Network"},{"name":"Department of Pediatrics, Division of Hematology, Oncology and Hemostaseology, Goethe University Frankfurt, Frankfurt\/Main, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Antolin","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Faculty of Health and Life Sciences, University of Exeter, Medical Research Council Center for Medical Mycology, Exeter, United Kingdom"},{"name":"European Pediatric Mycology Network"},{"name":"Pediatric Infectious Diseases and Immunology Unit, St George\u2019s University Hospitals, NHS Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Mesini","sequence":"additional","affiliation":[{"name":"European Pediatric Mycology Network"},{"name":"Pediatric Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha A.","family":"Alkhaaldi","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Ireland at Crumlin, Crumlin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Baquero-Artigao","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz, IdiPAZ. CIBERINFEC, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benhur S.","family":"Cetin","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Faculty of Medicine, Erciyes University, Kayseri, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ebrahimi-Fakhari","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology, University Children\u2019s Hospital, Infectious Disease Research Program, Center for Bone Marrow Transplantation, Muenster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2822-3527","authenticated-orcid":false,"given":"Marieke","family":"Emonts","sequence":"additional","affiliation":[{"name":"Paediatric Immunology, Infectious Diseases and Allergy Dept, Great North Children\u2019s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"},{"name":"Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4103-2837","authenticated-orcid":false,"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Pediatric Clinic, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Fainardi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Parma, Pediatric Clinic, Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Ghimenton-Walters","sequence":"additional","affiliation":[{"name":"Paediatric Immunology, Infectious Diseases and Allergy Dept, Great North Children\u2019s Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gij\u00f3n","sequence":"additional","affiliation":[{"name":"Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba G.","family":"Guerrero","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos D.","family":"Grasa","sequence":"additional","affiliation":[{"name":"Hospital Universitario La Paz, IdiPAZ. CIBERINFEC, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igne","family":"Kairiene","sequence":"additional","affiliation":[{"name":"Center for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania"},{"name":"Clinics of Children\u2019s Diseases, Faculty of Medicine, Vilnius University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelija","family":"Kildonaviciute","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-9295","authenticated-orcid":false,"given":"Maria","family":"Kourti","sequence":"additional","affiliation":[{"name":"Third Department of Pediatrics, Infectious Diseases Unit, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Manzanares","sequence":"additional","affiliation":[{"name":"Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mendoza-Palomar","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d\u2019Hebron, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Noni","sequence":"additional","affiliation":[{"name":"1st Department of Pediatrics, National and Kapodistrian University of Athens, \u201cAgia Sophia\u201d Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Papakonstantinou","sequence":"additional","affiliation":[{"name":"Pediatric Oncology Department, Hippokration Hospital of Thessaloniki, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Paulus","sequence":"additional","affiliation":[{"name":"Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Perwein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Rascon","sequence":"additional","affiliation":[{"name":"Center for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania"},{"name":"Clinics of Children\u2019s Diseases, Faculty of Medicine, Vilnius University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Rinc\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Soler-Palacin","sequence":"additional","affiliation":[{"name":"Pediatric Infectious Diseases and Immunodeficiencies Unit, Hospital Universitari Vall d\u2019Hebron, Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Solopova","sequence":"additional","affiliation":[{"name":"Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Spoulou","sequence":"additional","affiliation":[{"name":"1st Department of Pediatrics, National and Kapodistrian University of Athens, \u201cAgia Sophia\u201d Children\u2019s Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Strenger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Tedford","sequence":"additional","affiliation":[{"name":"Children\u2019s Health Ireland at Crumlin, Crumlin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Tzika","sequence":"additional","affiliation":[{"name":"Third Department of Pediatrics, Infectious Diseases Unit, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borbala","family":"Zsigmond","sequence":"additional","affiliation":[{"name":"Heim Pal Children Hospital, Hungary, Budapest"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-364X","authenticated-orcid":false,"given":"Emmanuel","family":"Roilides","sequence":"additional","affiliation":[{"name":"Third Department of Pediatrics, Infectious Diseases Unit, Aristotle University School of Medicine, Hippokration Hospital, Thessaloniki, Greece"},{"name":"European Pediatric Mycology Network"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"R1-20260422","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1097\/INF.0000000000003967","article-title":"Antifungal stewardship programs in children: challenges and opportunities","volume":"42","author":"Kourti","year":"2023","journal-title":"Pediatr Infect Dis J"},{"issue":"suppl_1","key":"R2-20260422","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/pix046","article-title":"Epidemiology of invasive fungal disease in children","volume":"6","author":"Pana","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R3-20260422","doi-asserted-by":"crossref","first-page":"e2016040","DOI":"10.4084\/mjhid.2016.040","article-title":"Antifungal prophylaxis in immunocompromised patients","volume":"8","author":"Vazquez","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R4-20260422","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/myc.12063","article-title":"Invasive fungal infections in paediatric acute myeloid leukaemia","volume":"56","author":"Johnston","year":"2013","journal-title":"Mycoses"},{"key":"R5-20260422","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/jpids\/pix030","article-title":"Risk factors for invasive fungal disease in pediatric cancer and hematopoietic stem cell transplantation: a systematic review","volume":"7","author":"Fisher","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R6-20260422","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QCO.0000000000001062","article-title":"Inborn errors of immunity and invasive fungal infections: presentation and management","volume":"37","author":"Paccoud","year":"2024","journal-title":"Curr Opin Infect Dis"},{"issue":"Suppl 1","key":"R7-20260422","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/imj.15586","article-title":"Consensus guidelines for antifungal stewardship, surveillance and infection prevention, 2021","volume":"51 Suppl 7","author":"Khanina","year":"2021","journal-title":"Intern Med J"},{"key":"R8-20260422","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1128\/AAC.04109-14","article-title":"Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) Study","volume":"59","author":"Lestner","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"R9-20260422","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/INF.0000000000003402","article-title":"Pediatric antifungal prescribing patterns identify significant opportunities to rationalize antifungal use in children","volume":"41","author":"Ferreras-Antol\u00edn","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20260422","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12879-021-05774-9","article-title":"Antifungal stewardship in a tertiary care paediatric hospital: the PROAFUNGI study","volume":"21","author":"Mendoza-Palomar","year":"2021","journal-title":"BMC Infect Dis"},{"key":"R11-20260422","doi-asserted-by":"crossref","first-page":"e27963","DOI":"10.1002\/pbc.27963","article-title":"Effect of an intervention to improve the prescription of antifungals in pediatric hematology-oncology","volume":"67","author":"Santiago-Garc\u00eda","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20260422","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/jac\/dkac060","article-title":"Antifungal use in children with acute leukaemia: state of current evidence and directions for future research","volume":"77","author":"Yeoh","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"R13-20260422","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/INF.0000000000004445","article-title":"Antifungal drug usage in european neonatal units: a multicenter weekly point prevalence study","volume":"43","author":"Chorafa","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"R14-20260422","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R15-20260422","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1016\/S1470-2045(20)30723-3","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Groll","year":"2021","journal-title":"Lancet Oncol"},{"key":"R16-20260422","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R17-20260422","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1749-6632.2012.06829.x","article-title":"Risk stratification for invasive aspergillosis in immunocompromised patients","volume":"1272","author":"Herbrecht","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"R18-20260422","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2013.136","article-title":"Predictors of invasive fungal infection in pediatric allogeneic hematopoietic SCT recipients","volume":"49","author":"Hol","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"R19-20260422","first-page":"2264","article-title":"Low-dose liposomal amphotericin B for antifungal prophylaxis in paediatric allogeneic haematopoietic stem cell transplantation","volume":"75","author":"Mendoza-Palomar","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"R20-20260422","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1080\/14656566.2024.2387686","article-title":"An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients","volume":"25","author":"Panagopoulou","year":"2024","journal-title":"Expert Opin Pharmacother"},{"key":"R21-20260422","doi-asserted-by":"crossref","first-page":"e0140930","DOI":"10.1371\/journal.pone.0140930","article-title":"Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia","volume":"10","author":"Fung","year":"2015","journal-title":"PLoS One"},{"key":"R22-20260422","doi-asserted-by":"crossref","first-page":"e13722","DOI":"10.1111\/myc.13722","article-title":"Systematic review on efficacy and safety of empirical versus pre-emptive antifungal therapy among children with febrile neutropenia reveals paucity of data","volume":"67","author":"Sachdeva","year":"2024","journal-title":"Mycoses"},{"key":"R23-20260422","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"suppl 7","key":"R24-20260422","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/1469-0691.12040","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp","volume":"18","author":"Hope","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"suppl_1","key":"R25-20260422","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1093\/jpids\/pix054","article-title":"Role of molecular biomarkers in the diagnosis of invasive fungal diseases in children","volume":"6","author":"Huppler","year":"2017","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R26-20260422","doi-asserted-by":"crossref","article-title":"Multicenter prospective study of biomarkers for diagnosis of invasive candidiasis in children and adolescents","author":"Fisher","DOI":"10.1093\/cid\/ciab928"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T08:01:50Z","timestamp":1776844910000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000003070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000003070","relation":{},"ISSN":["1077-4114","1536-3678"],"issn-type":[{"value":"1077-4114","type":"print"},{"value":"1536-3678","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]},"assertion":[{"value":"2024-12-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}